Company: DHR
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0000313616-25-000081
Chunk: 1

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 1
---
, to our shareholders on or about March 26, 2025.

Voting Matters

| Proposal                                                                                               |     | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |     | Board Recommendation |     |                 |
| PROPOSAL 1–Election of directors(page12)                                                               |     | We are asking our shareholders to elect each of the thirteen directorsidentified below to serve until the2026Annual Meeting of Shareholders.                                                                                                                                                                                                                                                                                                                                    |     | ü                    |     | FOReach nominee |
| PROPOSAL 2–Ratification of the appointmentof the independent registered publicaccounting firm (page36) |     | We are asking our shareholders to ratify our Audit Committee’s selectionof Ernst & Young LLP (“E&Y”) to act as the independent registered publicaccounting firm for Danaher for 2025. Although our shareholders are notrequired to approve the selection of E&Y, our Board of Directors (the "Board") believes that it isadvisable to give our shareholders an opportunity to ratify this selection.                                                                            |     | ü                    |     | FOR             |
| PROPOSAL 3–Advisory vote to approvenamed executive officer compensation(page71)                        |     | We are asking our shareholders to cast a non-binding, advisory voteon the compensation of the executive officers named in the 2024 SummaryCompensation Table (the “named executive officers” or “NEOs”) on page53. Inevaluating this year’s “say on pay” proposal, we recommend that youreview our Compensation Discussion and Analysis, which explainshow and why the Compensation Committee of our Board arrived at itsexecutive compensation actions and decisions for 2024. |     | ü                    |     | FOR             |

| 2025 Notice of Annual Meeting and Proxy Statement |     | 4 |

Please see the sections titled “General Information About the Meeting” and “Other Information” beginning on pages 72and 75respectively, for important information about the proxy materials, voting, the Annual Meeting, Company documents, communications and the deadlines to submit shareholder proposals and director nominations for next year’s annual meeting of shareholders.

### Business Highlights
2024 Performance

Following the separation of three of our lines of business over the past decade, 2024 marked Danaher’s first full year as a more strategically focused life sciences and diagnostics company. During the year we continued to invest in Danaher’s future growth, investing approximately $1.6 billion in research and development and approximately